Skip to main content
OpenTrials

Clinical trial condition

Stage IV Pancreatic Cancer

Explore clinical trials studying Stage IV Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

70 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage IV Pancreatic Cancer trial results

Completed

Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer

NCT01666730

Conditions
Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

NCT03222258

Conditions
Biliary Cancer Metastatic, Breast Diseases, Breast Neoplasms, +40 more
Locations
  • National Cancer Center, Korea Goyang-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Gyeongsang National University Hospital Jinju, Gyeongsangnam-do, South Korea
  • Chonbuk National University Hospital Jeonju, Jeollabuk-do, South Korea
View all 15 locations
View Trial Details
Completed

Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer

NCT02050178

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Hospital Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer

NCT02005315

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Hospital Anschutz Cancer Pavillion Aurora, Colorado, United States
  • Indiana University Simon Cancer Center Indianapolis, Indiana, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions